NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker ratCARR, Richard D; BRAND, Christian L; BODVARSDOTTIR, Thora B et al.Diabetes (New York, NY). 2003, Vol 52, Num 10, pp 2513-2518, issn 0012-1797, 6 p.Article

Inhibition of insulin secretion as a new drug target in the treatment of metabolic disordersBONDO HANSEN, J; ARKHAMMAR, Per O. G; BODVARSDOTTIR, Thora B et al.Current medicinal chemistry. 2004, Vol 11, Num 12, pp 1595-1615, issn 0929-8673, 21 p.Article

Subdiaphragmatic vagal deafferentation affects body weight gain and glucose metabolism in obese male zucker (fa/fa) ratsFERRARI, Bettina; ARNOLD, Myrtha; CARR, Richard D et al.American journal of physiology. Regulatory, integrative and comparative physiology. 2005, Vol 58, Num 4, pp R1027-R1034, issn 0363-6119Article

Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesusVEDTOFTE, Louise; BODVARSDOTTIR, Thora B; GOTFREDSEN, Carsten F et al.Regulatory peptides. 2010, Vol 160, Num 1-3, pp 106-114, issn 0167-0115, 9 p.Article

New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cellsNIELSEN, Flemming E; EBDRUP, Søren; WAHL, Philip et al.Journal of medicinal chemistry (Print). 2006, Vol 49, Num 14, pp 4127-4139, issn 0022-2623, 13 p.Article

6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate atp sensitive potassium channels of pancreatic β-cellsNIELSEN, Flemming E; BODVARSDOTTIR, Thora B; JUNAGER, Finn et al.Journal of medicinal chemistry (Print). 2002, Vol 45, Num 19, pp 4171-4187, issn 0022-2623Article